Hormonal

Metformin therapy reduces the incidence of new-onset type 2 diabetes in high-risk adults (BMI ≥35, age 25-59, fasting glucose ≥110 mg/dL, or prior gestational diabetes) and provides long-term cardiovascular and microvascular benefits.

If you are at high risk for type 2 diabetes (overweight, older than 25, or have a history of gestational diabetes), metformin can help prevent the disease. It is cost-effective and provides long-term benefits even after stopping the drug. Discuss with your doctor if you are a candidate, especially if lifestyle changes alone are insufficient.